Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines

Scandinavian Journal of Immunology

Volumn 44, Issue 5, 1996, Pages 493-500

  Steel, D M ^a   Donoghue, F C ^a   O'Neill, R M ^a   Uhlar, C M ^a   Whitehead, A S ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; DEXAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL LINE; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029840517     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-341.x     Document Type: Article

References (39)

1. Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977;74:4025-8.
2. Eriksen N, Benditt EP. Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein. Proc Natl Acad Sci USA 1980;77:6860-4.
3. Marhaug G. Three assays for the characterization and quantitation of human serum amyloid A. Scand J Immunol 1983; 18:329-38.
4. Woo P, Sipe J, Dinarello CA, Colten HR. Structure of a human serum amyloid A gene and modulation of its expression in transfected L cells. J Biol Chem 1987;262:15790-5.
5. Sipe JD, Colten HR, Goldberger G et al. Serum amyloid A (SAA): biosynthesis and post-synthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry 1985;24:2931-6.
6. Dwulet FE, Wallace DK, Benson MD. Amino acid structures of multiple forms of amyloid related serum protein SAA from a single individual. Biochemistry 1988;27:1677-82.
7. Kluve-Beckerman B, Dwulet FE, Benson MD. Human serum amyloid A: Three hepatic mRNAs and the corresponding proteins in one person. J Clin Invest 1988;82:1670-5.
8. Beach CM, deBeer MC, Sipe JD, Loose LD, deBeer FC. Human serum amyloid A protein: Complete amino acid sequence of a new variant. Biochem J 1992;282:615-20.
9. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation into amyloid fibrils in vivo. Scand J Immunol 1988;28:317-24.
10. Whitehead AS, deBeer MC, Steel DM et al. Identification of novel members of the serum amyloid A protein (SAA) superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992;267:3862-7.
11. deBeer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, deBeer FC. Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res 1995;35:526-34.
12. Benson MD, Aldo-Benson MA. Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol 1979;122:2077-82.
13. Aldo-Benson MA, Benson M. SAA suppression of immune response in vitro : Evidence for an effect on T cell-macrophage interaction. J Immunol 1982;128:2390-2.
14. Linke RP, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Acta 1991;176: 1100-5.
15. Badolato R, Wang JM, Murphy WJ et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1995;180:203-9.
16. Xu L, Badolato R, Murphy WJ et al. A novel biologic function of serum amyloid A: Induction of T lymphocyte migration and adhesion. J Immunol 1995;155:1184-90.
17. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, deBeer FC. Serum amyloid A-containing human high density lipoprotein 3: density, size and apolipoprotein composition. J Biol Chem 1986:261:9644-51.
18. Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1989;1006:173-8.
19. Liang JS, Sipe JD. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J Lipid Res 1995;36:37-46.
20. Pruzanski W, deBeer FC, deBeer MC, Stefanski E, Vadas P. Serum amyloid A protein enhances the activity of secretory nonpancreatic phospolipase A2. Biochem J 1995;309:461-4.
21. Kisilevsky R. Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. Lab Invest 1992;66:778-85.
22. Ramadori G, Sipe JD, Colten HR. Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol 1985;135:3645-7.
23. Meek RL, Benditt EP. Amyloid A gene family expression in different mouse tissues. J Exp Med 1986:164:2006-17.
24. Meek RL, Eriksen N, Benditt EP. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992;89:7949-52.
25. Meek RL, Benditt EP. Rat tissues express serum amyloid A protein-related mRNAs. Proc Natl Acad Sci USA 1989;86: 1890-4.
26. Webb CF, Tucker PW, Dowton SB. Expression and sequence analysis of serum amyloid A in the Syrian hamster. Biochemistry 1989;28:4785-90.
27. Brinckerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B, Benson MD. Autocrine induction of collagenase by serum amyloid A-like and β2-microglobulin-like proteins. Science 1989;243:655-7.
28. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function. Proc Natl Acad Sci USA 1995;91:3186-90.
29. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP. Human serum amyloid A genes are expressed in monocytic macrophage cell lines. Am J Path 1994;145:650-60.
30. Steel DM, Rogers JT, deBeer MC, deBeer FC, Whitehead AS. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency. Biochem J 1993;291: 701-7.
31. Sierra F, Lichtler A, Marashi F et al. Organization of human histone genes. Proc Natl Acad Sci USA 1982;79:1795-9.
32. Auffray C, Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1980;107:303-14.
33. Steel DM, Whitehead AS. Heterogenous modulation of acutephase-reactant mRNA levels by interleukin-1 and interleukin-6 in the human hepatoma cell line PLC/PRF/5. Biochem J 1991;277:477-82.
34. Ganapathi MK, May LT, Schultz D et al. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 1988;157:271-7.
35. McAdam KPWJ, Li J, Knowles J et al. The biology of SAA: identification of the inducer, in vitro synthesis and heterogeneity demonstrated with monoclonal antibodies. Ann NY Acad Sci 1982;389:126-36.
36. Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (1L6/BSF/ HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 1988;232:347-50.
37. Ganapathi MK, Schultz D, Mackiewicz A et al. Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep3B cells. J Immunol 1988;141:564-69.
38. Jiang SL, Lozanski G, Samols D, Kushner I. Induction of Human Serum amyloid A in Hep3B cells by IL-6 and IL-13 involves both transcriptional and post-transcriptional mechanisms. J Immunol 1995;154:825-31.
39. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-8.